Literature DB >> 7043898

Malaria: immunity and prospects for vaccination.

M Hommel.   

Abstract

Malaria infections elicit a complex chain of cellular events which can, in some instances, lead to a state of immunity. Although there is strong evidence that a collaboration between specific antibodies and activated macrophages plays the central effector role in malaria immunity, alternative interpretations are possible. It is, for example, not known which malarial antigens are essential for triggering the critical effector functions and how these antigens are presented to the immune system. Under these circumstances, it is not surprising that the search for a vaccine against malaria has used rather empirical methods. Three invasive stages of the parasite (merozoites, sporozoites and gametes) have so far shown a potential efficiency in inducing protection in experimental models, but there is much to be done before vaccination can be an effective tool in malaria control.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7043898      PMCID: PMC1273171     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  152 in total

1.  Does a histidine-rich protein from Plasmodium lophurae have a function in merozoite penetration?

Authors:  A Kilejian
Journal:  J Protozool       Date:  1976-05

2.  Babesia microti and Plasmodium berghei yoelii infections in nude mice.

Authors:  I A Clark; A C Allison
Journal:  Nature       Date:  1974-11-22       Impact factor: 49.962

3.  Complement in acute experimental malaria. II. Alterations in the components of complement.

Authors:  N R Cooper; B J Fogel
Journal:  Mil Med       Date:  1966-09       Impact factor: 1.437

4.  Plasmodium gallinaceum: Transmission-blocking immunity in chickens. II. The effect of antigamete antibodies in vitro and in vivo and their elaboration during infection.

Authors:  R Carter; R W Gwadz; I Green
Journal:  Exp Parasitol       Date:  1979-04       Impact factor: 2.011

5.  Splenic mediated erythrocyte cytotoxicity in malaria.

Authors:  R M Coleman; N J Rencricca; J P Stout; W H Brissette; D M Smith
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

6.  Cell-mediated immunity in mice vaccinated against malaria.

Authors:  B J Cottrell; J H Playfair; B J De Souza
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

7.  T and B cell population changes in young and in adult rats infected with Plasmodium berghei.

Authors:  S M Gravely; J Hamburger; J P Kreier
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

8.  Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite.

Authors:  R R Freeman; A J Trejdosiewicz; G A Cross
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

9.  Immunity to Plasmodium berghei in rats: passive serum transfer and role of the spleen.

Authors:  I N Brown; R S Phillips
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

10.  Antigenicity of the infected-erythrocyte and merozoite surfaces in Falciparum malaria.

Authors:  S G Langreth; R T Reese
Journal:  J Exp Med       Date:  1979-11-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Future potential of malaria vaccines.

Authors:  M Hommel
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

2.  Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status.

Authors:  P Druilhe; S Khusmith
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

3.  Severe malaria in a splenectomised Gabonese woman.

Authors:  Martin P Grobusch; Steffen Borrmann; Justin Omva; Saadou Issifou; Peter G Kremsner
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

4.  Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen.

Authors:  M Hommel; P H David; L D Oligino
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.